Summary

Asia Pacific Blood Glucose Monitoring Devices Market is valued at approximately USD 2.52 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.82% over the forecast period 2024-2032. Blood glucose monitoring devices are tools used to measure the amount of glucose, or sugar, in the blood. There are two main types of blood glucose monitoring devices: blood sugar meters, and continuous glucose monitors. Blood glucose monitoring devices are used by people with diabetes to monitor their blood sugar levels and help them manage their condition. By monitoring their blood sugar levels, people with diabetes can make sure their levels are in a healthy range and adjust their diet, exercise, or medication as needed. Also, there is a significant rise in the adoption of continuous glucose monitoring (CGM) systems and flash glucose monitoring (FGM) devices. These advanced technologies provide real-time data, improving diabetes management. Integration of digital health platforms and mobile applications with glucose monitoring devices allows for better tracking, analysis, and management of blood glucose levels.

Additionally, the increasing incidence of diabetes in the Asia-Pacific region is a significant driver for the growth of the Asia Pacific Blood Glucose Monitoring Devices Market. Lifestyle changes, urbanization, and an aging population contribute to the growing number of diabetic patients, which boosts the demand for blood glucose monitoring devices. Also, rising healthcare spending in many Asia-Pacific countries is enabling better access to diabetes management tools. Increased healthcare budgets and improved insurance coverage make these devices more affordable and accessible to the population. Additionally, there is a growing trend towards home healthcare due to convenience and cost-effectiveness. Blood glucose monitoring devices are an essential part of home diabetes management, leading to increased market demand. However, the limited reimbursement policies and high cost of devices are expected to hinder the market growth during the forecast period 2024-2032.

The key Countries considered for the Asia Pacific Blood Glucose Monitoring Devices market study includes China, India, Japan, South Korea, Australia and the Rest of Asia Pacific. In 2023, China was the largest regional market in terms of revenue. The Chinese government has been actively promoting healthcare reforms and increasing accessibility to medical devices, including blood glucose monitoring devices. Policies aimed at improving healthcare infrastructure and providing subsidies for essential medical equipment have boosted market growth. Also, China has been experiencing a rise in diabetes cases due to changing lifestyles, urbanization, and dietary habits. This growing prevalence of diabetes drives the demand for blood glucose monitoring devices. Moreover, India is expected to grow with the highest CAGR during the forecast period 2024-2032.

Major market players included in this report are:
Bioland Technology Limited
Biosense Technologies Private Limited
Taidoc Technology Corporation
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:
By Product
Self-monitoring Devices
Continuous Blood Glucose Monitoring Devices

By End-use
Hospitals
Home Care
Diagnostic Centers
By Region:
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Asia Pacific Blood Glucose Monitoring Devices Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Asia Pacific Blood Glucose Monitoring Devices Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Product
2.3.2. By End-use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Asia Pacific Blood Glucose Monitoring Devices Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Asia Pacific Blood Glucose Monitoring Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Asia Pacific Blood Glucose Monitoring Devices Market Size & Forecasts by Product 2022-2032
5.1. Self-monitoring Devices
5.2. Continuous Blood Glucose Monitoring Devices
Chapter 6. Asia Pacific Blood Glucose Monitoring Devices Market Size & Forecasts by End-use 2022-2032
6.1. Hospitals
6.2. Home Care
6.3. Diagnostic Centers
Chapter 7. Asia Pacific Blood Glucose Monitoring Devices Market Size & Forecasts by Country 2022-2032
7.1. China Blood Glucose Monitoring Devices Market
7.1.1. Product breakdown size & forecasts, 2022-2032
7.1.2. End-use breakdown size & forecasts, 2022-2032
7.2. India Blood Glucose Monitoring Devices Market
7.3. Japan Blood Glucose Monitoring Devices Market
7.4. Australia Blood Glucose Monitoring Devices Market
7.5. South Korea Blood Glucose Monitoring Devices Market
7.6. Rest of Asia Pacific Blood Glucose Monitoring Devices Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Bioland Technology Limited.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Biosense Technologies Private Limited
8.3.3. Taidoc Technology Corporation
8.3.4. Company 4
8.3.5. Company 5
8.3.6. Company 6
8.3.7. Company 7
8.3.8. Company 8
8.3.9. Company 9
8.3.10. Company 10
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes